● On September 25, a new class 1 biological new drug "freeze dried powder of Clostridium gloeosporioides for injection" was granted the clinical trial acceptance number of cxsl2000177; on September 9, it was approved by the clinical trial, becoming the first bacteria treatment solid tumor drug approved by clinical trial in the world, opening a new era of "bacterial oncolysis"
● One project acceptance of Jinan Golden Seed promotion plan was completed
● Wang Yong, senior engineer, won "Shandong May 1st Labor Medal"
● It has passed the quality management system certification of GB / t19001-2016 / is09001:2015
● * won the title of "Shandong bacterial anti-tumor drug precision medical engineering laboratory"
● To undertake a major national new drug development science and technology project
Undertake one major innovation project in Shandong Province
● Won the first place in Shandong Province small and medium enterprises innovation competition action plan (Biomedical group)
● Won the excellent enterprise award of China Innovation and Entrepreneurship Competition
● Won the first prize of provincial and ministerial technological innovation achievements
● Wang Yong, senior engineer, won the "Jinan May 1st Labor Medal" and "the most beautiful scientific and technological worker in Jinan high tech Zone"
● Yu Na, senior engineer, won the May 1st Labor Medal of Shandong Petrochemical and pharmaceutical system trade union
● "Shandong Provincial National Talent Engineering Expert workstation"
● Won the title of "Shandong gazelle enterprise top 10 independent innovation"
● Won the title of "Jinan specialized and special new small and medium sized enterprise"
● Won the "five star party organization"
● Invention patent (zl201210310374.4) won China Patent Excellence Award
● Undertake one project of Jinzhong promotion project in Jinan City
● One expert of "national talent project" was independently cultivated,
● Professor Wei, chief scientist, won the science and technology Figure Award of "influencing Jinan" in 2018
● Establishment of an overseas research and development institution -- Sino US bacterial drug pharmacology Analysis Center
● Shandong Jingji bioengineering Center
● "Shandong gazelle enterprise"
● Awarded "Jinan post doctoral innovation practice workstation"
● Won the "five star party organization"
● It has undertaken 2 innovative projects in Shandong Province
● Undertake one project of Jinzhong promotion project in Jinan City
● It won the fourth place in Shandong Province's small and medium-sized enterprises innovation competition action plan (Biomedical group), and was successfully shortlisted in China Innovation and entrepreneurship competition
● Won the title of "100 most growing entrepreneurial enterprises in China Overseas Students Pioneer Park"
● Won "the first batch of academician workstation in Jinan"
● Awarded "Jinan intellectual property (patent) advantage cultivation enterprise"
● Buy out all shares of Australian side and change its name to "Shandong Xinchuang Biotechnology Co., Ltd"
● Purchase Hanyu Jingu a2-3 building 7 floors (1800 square meters) for high standard decoration
● Won the title of "national high tech enterprise"
● Won the title of "academician workstation of Shandong Province"
● Awarded "Jinan tumor biological immune technology" Engineering Laboratory
● Shandong Xingwei biomedical Co., Ltd., a Sino Australian joint venture, was established to officially carry out the research and development of a new class 1 new drug Clostridium gloeosporioides
● Undertaking one key scientific and technological project in Shandong Province
● Undertaking one science and technology development plan of Jinan
